Francisco, R., Moreira, T., Silva, P. D., Brandao, A. C., Zurawski, J., Tauhid, S., Jinich, A., Sullivan, J., Baecher-Allen, C., Singhal, T., Bakshi, R., Chitnis, T., Weiner, H. (2026). Integrated multiomics profiling reveals MS-specific molecular signatures linked to progression and response to nasal anti-CD3 (Foralumab) therapy 2267524. The Journal of Immunology. https://doi.org/10.1093/jimmun/vkag141.1159